School of Medicine


Showing 1-7 of 7 Results

  • Afrin N. Kamal

    Afrin N. Kamal

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    Bio Afrin Kamal is a board-certified gastroenterologist, who trained at Washington University in internal medicine, Cleveland Clinic in gastroenterology/hepatology, and most recently Stanford University in esophageal and motility diseases. Afrin shares a clinical passion in esophageal motility diseases with an an overlapping interest in health services and outcomes research.

  • Kian Keyashian

    Kian Keyashian

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    Bio The management of inflammatory bowel disease has changed dramatically especially over the past 5-10 years, with the introduction of biologic and small molecule therapies and new goals of treatment, with an emphasis on healing the bowel. My career goal since my graduation from IBD fellowship in 2012 has been to improve the outcomes and quality of life of patients with inflammatory bowel disease. In line with these goals, my research has focused investigating new noninvasive diagnostic test, finding factors early in the disease course that might predict a more aggressive disease course and need for different therapies, and investigating new promising effective medications with less side effects.

  • W. Ray Kim, MD

    W. Ray Kim, MD

    Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center

    Bio Chronic liver disease is one of the most common causes of premature death in Americans. My career goal is to improve the outcome of individuals with chronic liver disease by identifying the optimal means for diagnosis, monitoring, treatment and prevention. The path I have chosen to achieve this goal is through engagement in clinical epidemiology and patient-oriented, effectiveness research.

    Since the development of the MELD score which recognizes the importance of renal function in the prognosis of patients with end stage liver disease, one of the areas that we have had intense interest has been acute and chronic renal injury in patients undergoing liver transplantation. Liver transplantation represents a unique opportunity for research, because of the potential for reversal of the renal injury as well as access to biological materials.

  • Radhika Kumari

    Radhika Kumari

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    Bio Dr Kumari?s clinical interests lie in taking care of patients with Hepatitis C , cirrhosis and complications, liver cancer and management of post transplant patients. Her research interests are doing Translational research in Portal Hypertension and its complications.

  • Paul Kwo

    Paul Kwo

    Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center

    Bio Dr. Kwo is currently Professor of Medicine and Director of Hepatology at the Stanford University where he joined the faculty in November 2016. Prior to joining the faculty at Stanford, he was at Indiana University for 21 years where he served as the Medical Director of Liver Transplantation. He has distinguished himself in the field of Hepatitis C therapeutics and has been the principal investigator on multiple international trials. He recently authored the ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.

  • Allison Kwong

    Allison Kwong

    Instructor, Medicine - Gastroenterology & Hepatology

    Current Research and Scholarly Interests Cirrhosis, portal hypertension, liver transplantation, transplant outcomes, organ allocation, population health, quality and systems improvement

Footer Links:

Stanford Medicine Resources: